News Medical on MSN1d
Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy
Researchers developed SNIPRs, innovative receptors that sense soluble ligands, enabling precise therapeutic control in CAR ...
Nature19d
Receptor seeks ligand: On the way to cloning the molecular receptors for sweet and bitter taste
The predicted membrane topology showed a long extracellular N terminal that presumably constitutes the ligand binding site. Homology with the Ca 2+ receptor CaSR of the parathyroid, with ...
EurekAlert!6d
EphA2 signaling in eye lens aging: wild-type, knockout, and aging mice
A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science ...
BioSpace7d
23andMe Cuts Headcount by 40%, Drops Drug Discovery Work
In line with the restructuring initiative, 23andMe is looking for strategic opportunities for its pipeline assets, including ...
Armed robbery in Revesby12d
How Physical Force Affects Cancer Treatment
Programmed Cell Death-1, or PD-1, has become a headline-grabbing molecule best known for its role in cancer immunotherapies called checkpoint ...
BioWorld12d
Aurigene Oncology presents new dual inhibitors of PD-L1 and adenosine receptors
Aurigene Oncology Ltd. has divulged compounds acting as dual antagonists of adenosine receptor A2A (ADORA2A) and programmed cell death 1 ligand 1 (CD274; PD-L1) reported to be useful for the treatment ...